These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6467944)

  • 21. A clinical and metabolic study of norethisterone oenanthate in Thai women.
    Virutamasen P; Nitichai Y; Tangkeow P; Kankeerati W; Rienprayura D; Boonsiri B
    Contraception; 1980 Oct; 22(4):397-408. PubMed ID: 7449388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver function tests in patients on oral progestogens.
    Engineer AD; Gupta V; Tandon P
    J Obstet Gynaecol India; 1968 Apr; 18(2):598-605. PubMed ID: 12331828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical evaluation of two monthly injectable contraceptives and their effects on some metabolic parameters.
    Haiba NA; el-Habashy MA; Said SA; Darwish EA; Abdel-Sayed WS; Nayel SE
    Contraception; 1989 Jun; 39(6):619-32. PubMed ID: 2666019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New long-acting injectable microcapsule contraceptive system.
    Beck LR; Cowsar DR; Lewis DH; Gibson JW; Flowers CE
    Am J Obstet Gynecol; 1979 Oct; 135(3):419-26. PubMed ID: 114054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Some metabolic effects of long-term use of the injectable contraceptive norethisterone oenanthate.
    Howard G; Blair M; Fotherby K; Trayner I; Hamawi A; Elder MG
    Lancet; 1982 Feb; 1(8269):423-5. PubMed ID: 6121092
    [No Abstract]   [Full Text] [Related]  

  • 26. Studies on the role of intestinal bacteria in metabolism of synthetic and natural steroid hormones.
    Adlercreutz H; Pulkkinen MO; Hämäläinen EK; Korpela JT
    J Steroid Biochem; 1984 Jan; 20(1):217-29. PubMed ID: 6231418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of intramuscular norethisterone oenanthate used as a contraceptive on intravenous glucose tolerance and on blood coagulation factors VII and X.
    Howard G; Myatt L; Elder MG
    Br J Obstet Gynaecol; 1977 Aug; 84(8):618-21. PubMed ID: 889752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a low-dose monthly injectable contraceptive system: I. Choice of compounds, dose and administration route.
    Garza-Flores J; Diaz-Sanchez V; Jimenez-Thomas S; Rudel HW
    Contraception; 1984 Oct; 30(4):371-9. PubMed ID: 6509988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized, single blind comparative trial of norethindrone enanthate and depo-medroxyprogesterone acetate in Bangladesh.
    Swenson I; Khan AR; Jahan FA
    Contraception; 1980 Mar; 21(3):207-15. PubMed ID: 6446442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased liver cytochrome P-450 in rats caused by norethindrone or ethynyloestradiol.
    White IN; Muller-Eberhard U
    Biochem J; 1977 Jul; 166(1):57-64. PubMed ID: 901418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin sensitivity is decreased in normal women by doses of ethinyl estradiol used in oral contraceptives.
    Kojima T; Lindheim SR; Duffy DM; Vijod MA; Stanczyk FZ; Lobo RA
    Am J Obstet Gynecol; 1993 Dec; 169(6):1540-4. PubMed ID: 8267059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subdermal norethindrone pellets -- a method for contraception?
    Odlind V; Moo-Young AJ; Gupta GN; Weiner E; Johansson ED
    Contraception; 1979 Jun; 19(6):639-48. PubMed ID: 487813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Release of 19-nor-testosterone type of contraceptive steroids through different drug delivery systems into serum and breast milk of lactating women.
    Toddywalla VS; Mehta S; Virkar KD; Saxena BN
    Contraception; 1980 Mar; 21(3):217-23. PubMed ID: 7389350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles.
    Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC
    Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contraception with progestagens in systemic lupus erythematosus.
    Mintz G; Gutiérrez G; Delezé M; Rodríguez E
    Contraception; 1984 Jul; 30(1):29-38. PubMed ID: 6434228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A clinical trial of norethisterone oenanthate (Norigest) injected every two months.
    Howard G; Blair M; Chen JK; Fotherby K; Muggeridge J; Elder MG; Bye PG
    Contraception; 1982 Apr; 25(4):333-40. PubMed ID: 7049569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of norethisterone in humans.
    Shi YE; He CH; Gu J; Fotherby K
    Contraception; 1987 May; 35(5):465-75. PubMed ID: 3621943
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of climacteric and postmenopausal women with 17-beta-oestradiol and norethisterone acetate.
    Furuhjelm M; Carlström K
    Acta Obstet Gynecol Scand; 1977; 56(4):351-61. PubMed ID: 602703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of different doses of norethisterone oenanthate.
    Fotherby K; Hamawi A; Howard G; Bye PG; Elder M
    Contraception; 1984 Apr; 29(4):325-33. PubMed ID: 6744856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hirsutism: metabolic effects of two commonly used oral contraceptives and spironolactone.
    Wild RA; Demers LM; Applebaum-Bowden D; Lenker R
    Contraception; 1991 Aug; 44(2):113-24. PubMed ID: 1893706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.